Herpes simplex virus type 2 in Brazil: seroepidemiologic survey. 1996

O L Da Rosa-Santos, and A Gonçalves Da Silva, and A C Pereira
Department of Medical Clinics (Dermatology), Clementino Fraga Filho University Hospital, Rio de Janeiro, Brazil.

BACKGROUND The incidence of genital herpes is increasing worldwide. Herpes simplex virus type 2 (HSV-2) is the most common cause of genital ulcerations among the sexually transmitted diseases (STDS). In order to investigate the sexual transmission of genital herpes infection in Brazil, the prevalence of specific antibodies to HSV-2, in populations of high and low risk for STDS was evaluated. METHODS The population at low risk for STDS was composed of 155 voluntary blood donors at the University Hospitals between February and August, 1994. The population at high risk for STDS was composed of 85 HIV-seropositive persons, consisting of homosexual and promiscuous heterosexual men. A group of 20 highly active prostitutes was also studied between May and July, 1994. All blood samples were screened using an enzyme-linked immunosorbent assay (ELISA) that detects type-specific antibodies to HSV-2 glycoprotein G. Before donating blood, all persons in the study group were given a questionnaire concerning risk factors for acquisition of STDS and suitable to show the socioepidemiologic characteristics of the subjects. RESULTS The prevalence of ELISA showing HSV-2 infections among HIV-seroposite persons, was 73% (P < 0.01). In the whole group at high risk for STDS, the prevalence was 72% (P < 0.05). Infection with HSV-2, as determined by seroprevalence, was significantly and independently associated with years of sexual activity, history of previous STDS, number of sexual partners in the previous month, number of pregnancies, and previous induced abortions, as well as the percentage of sexual acts involving receptive anal intercourse. CONCLUSIONS The current strategy for diagnosing genital HSV-2 infection misses many cases. Newly developed type-specific serologic methods can identify cases of unrecognized or subclinical infection. With the high seroprevalence rates detected, routine screening for HSV-2-specific antibodies should be considered in populations at high risk for STDS.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011477 Sex Work The act or practice of engaging in sexual relations for money or other benefit. Commercial Sex,Prostitution,Sex Industry,Industries, Sex,Sex Industries,Sex, Commercial,Work, Sex
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D001938 Brazil A country located on the eastern coast of South America, located between Colombia and Peru, that borders the Atlantic Ocean. It is bordered on the north by Venezuela, Guyana, Suriname, and French Guiana, on the south by Uruguay, and on the west by Argentina. The capital is Brasilia.
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006558 Herpes Genitalis Infection of the genitals (GENITALIA) with HERPES SIMPLEX VIRUS in either the males or the females. Genital Herpes,Herpes Simplex, Genital,Herpes Simplex Virus Genital Infection,Genital Herpes Simplex,Herpes, Genital
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III

Related Publications

O L Da Rosa-Santos, and A Gonçalves Da Silva, and A C Pereira
April 1981, The Indian journal of medical research,
O L Da Rosa-Santos, and A Gonçalves Da Silva, and A C Pereira
July 1989, The New England journal of medicine,
O L Da Rosa-Santos, and A Gonçalves Da Silva, and A C Pereira
January 1993, Revista do Instituto de Medicina Tropical de Sao Paulo,
O L Da Rosa-Santos, and A Gonçalves Da Silva, and A C Pereira
July 2000, The new microbiologica,
O L Da Rosa-Santos, and A Gonçalves Da Silva, and A C Pereira
January 1976, Survey of ophthalmology,
O L Da Rosa-Santos, and A Gonçalves Da Silva, and A C Pereira
January 1986, Yonsei medical journal,
O L Da Rosa-Santos, and A Gonçalves Da Silva, and A C Pereira
May 1977, Obstetrics and gynecology,
O L Da Rosa-Santos, and A Gonçalves Da Silva, and A C Pereira
August 1988, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi,
O L Da Rosa-Santos, and A Gonçalves Da Silva, and A C Pereira
March 2003, Nihon rinsho. Japanese journal of clinical medicine,
O L Da Rosa-Santos, and A Gonçalves Da Silva, and A C Pereira
January 2013, AIDS (London, England),
Copied contents to your clipboard!